There are 3397 resources available
Concluding remarks
Presenter: Thomas Powles
Session: ESMO Colloquium supported by Eisai Europe Ltd.: Optimising outcomes for patients with advanced renal cancer
Resources:
Slides
Webcast
LBA1 - CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC
Presenter: Tina Cascone
Session: Presidential 1
Resources:
Abstract
Slides
Webcast
945MO - AdvanTIG-206: Phase II randomized open-label study of ociperlimab (OCI) + tislelizumab (TIS) + BAT1706 (bevacizumab biosimilar) versus TIS + BAT1706 in patients (pts) with advanced hepatocellular carcinoma (HCC)
Presenter: Ming Mo Hou
Session: Mini oral session 1 - Gastrointestinal tumours, upper digestive
Resources:
Abstract
Slides
Webcast
1020MO - AdvanTIG-203: Phase II randomized, multicenter study of ociperlimab (OCI) + tislelizumab (TIS) in patients (pts) with unresectable, locally advanced, recurrent/metastatic esophageal squamous cell carcinoma (ESCC) and programmed cell death-ligand 1 (PD-L1) positivity
Presenter: Feng Wang
Session: Mini oral session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Presentation of case/condition: Non-muscle invasive bladder cancer (NMIBC) progressing to MIBC
Presenter: Andrea Necchi
Session: Bladder preservation strategies
Resources:
Slides
Webcast
Improving early diagnosis through screening programme guidelines: The case of lung cancer
Presenter: Jan Van Meerbeeck
Session: The importance of secondary prevention: Early detection and screening programmes
Resources:
Slides
Webcast
Clinical data of genomic subtypes of mCRC (MSI, BRAF V600, HER2, KRAS G12C, NTRK)
Presenter: Myriam Chalabi
Session: Biomarkers in metastatic colorectal cancer: What has changed in the last few years?
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Kjetil Boye
Session: New mechanisms and drugs for the treatment of patients with sarcomas
Resources:
Slides
Webcast
LBA2 - ALINA: Efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK+ non-small cell lung cancer (NSCLC)
Presenter: Ben Solomon
Session: Presidential 1
Resources:
Abstract
Slides
Webcast
94MO - Advanced extrahepatic cholangiocarcinoma: Post-hoc analysis of the ABC-01, -02 and -03 clinical trials
Presenter: Angela Lamarca
Session: Mini oral session 1 - Gastrointestinal tumours, upper digestive
Resources:
Abstract
Slides
Webcast